Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00100932
Status:
COMPLETED
Last Update Posted:
2012-03-27
First Post:
2005-01-07
Brief Title:
Phase II Study Of E7389 Halichondrin B Analogue In Patients With Advanced Non-Small Cell Lung Cancer NSCLC Who Progressed During Or After Platinum-Based Doublet Chemotherapy
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Organization Data
Organization:
Eisai Inc
Class:
INDUSTRY
Study ID:
E7389-A001-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eisai Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None